⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

176.93USD

-1.7800 (-1.00%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on RGEN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 176.93
P/E270.4
Dvd Ind Yld0.0%
P/B5.32
P/S14.3
Curr EV/T12M EBITDA68.8
Mkt Cap (USD)11.2B
Curr EV (USD)9.9B
2)

Per Share Data

EPS T12M0.48
DPS—
Bk Val Per Sh37.43
Rev/Sh13.86
Cash/Sh14.36
Curr Shares Out63.5M
FCF/Sh1.98
3)

Cash Flow Analysis

P/CF83.3
Curr P/FCF100.3
CF/NI3.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales17.2%
Eff Interest Rate4.1%
4)

Growth Potential

Dil EPS 1Y Gr287.0%
Cap 1Y Gr6.0%
BPS 1Y Gr5.6%
R&D To Sales7.2%
Retention Rate100.0%
Rev 1Y Gr16.4%
FCF 1Y Gr-37.3%
Assets 1Y Gr4.2%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin8.2%
Pretax Margin6.6%
Net Margin5.3%
ROA1.4%
ROE2.0%
ROC1.8%
Asset Turnover0.27
6)

Structure

Current Ratio9.05
Quick Ratio7.30
Debt/Assets23.4%
Debt/Com Eq32.7%
Net Debt/EBITDA0.59
Tot Debt/Capital24.7%
Gross Margin53.8%
EBIT/Int Exp2.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.